Canandaigua National Corp’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$360K Sell
2,827
-10
-0.4% -$1.16K 0.06% 190
2022
Q3
$297K Hold
2,837
0.05% 199
2022
Q2
$298K Sell
2,837
-105
-4% -$12.5K 0.05% 196
2022
Q1
$376K Sell
2,942
-266
-8% -$32.1K 0.06% 197
2021
Q4
$396K Sell
3,208
-34
-1% -$4.45K 0.06% 199
2021
Q3
$461K Buy
3,242
+85
+3% +$12.5K 0.08% 180
2021
Q2
$493K Buy
3,157
+25
+0.8% +$4.05K 0.08% 172
2021
Q1
$487K Sell
3,132
-20
-0.6% -$3.1K 0.08% 170
2020
Q4
$472K Buy
3,152
+6
+0.2% +$847 0.08% 167
2020
Q3
$416K Hold
3,146
0.07% 173
2020
Q2
$365K Buy
+3,146
New +$363K 0.07% 178

Other funds holding ZBH

Canandaigua National Corp's ZBH Position: Q4 2022 in Review

Canandaigua National Corp reduced its Zimmer Biomet (ZBH) stake by 0.35% in Q4 2022, selling an estimated $1.16K and leaving 2,827 shares worth $360K. The position accounts for 0.06% of the portfolio, ranked #190.

Canandaigua National Corp first reported a position in ZBH in Q2 2020 and has held it in 11 quarters since. The position peaked at $493K in Q2 2021. 977 funds tracked by Wall St. Rank hold ZBH as of Q4 2022.

  • Canandaigua National Corp held 2,827 shares of Zimmer Biomet worth $360K as of Q4 2022.
  • Canandaigua National Corp sold 10 Zimmer Biomet shares in Q4 2022, an estimated $1.16K.
  • Zimmer Biomet made up 0.06% of Canandaigua National Corp's portfolio in Q4 2022, its #190 holding.
  • Canandaigua National Corp first reported a position in Zimmer Biomet in Q2 2020 and has held it in 11 quarters since.
  • Canandaigua National Corp's Zimmer Biomet position peaked at $493K in Q2 2021.
  • 977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2022.

Based on Canandaigua National Corp's 13F filing for Q4 2022, filed 25 Jan 2023.